Description
As a dual rather than triple agonist, tirzepatide gives researchers a reference point for isolating the combined contribution of GIP and GLP-1 receptor activity, independent of glucagon receptor engagement. It is frequently used in comparative research alongside single-receptor GLP-1 agonists and triple agonists to map how additive GIP signaling changes insulin secretion dynamics, gastric emptying, and energy intake regulation in laboratory models.
Research Applications
- Dual GIP/GLP-1 receptor agonism studies
- Comparative incretin pathway research
- Insulin secretion and glucose handling models
- Gastric emptying and appetite signaling research
- Receptor binding and pharmacokinetic characterization
Disclaimer For laboratory research use only. Not for human consumption, clinical use, veterinary use, diagnosis, or therapeutic application.





Reviews
There are no reviews yet.